Article

From CGRP to PACAP: Unraveling the Next Chapter in Migraine Treatment

2023-10-17

Abstract excerpt

Migraine is a neurovascular disorder that can be debilitating for individuals and society. Current research focuses on finding effective analgesics and management strategies for migraines by targeting specific receptors and neuropeptides. Nevertheless, the responder rates of recently approved calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) and receptor inhibitors remain around 50 percent. To ad...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 622c4401-2ba4-5754-8bfd-44de630e46df
DOI: 10.20944/preprints202309.0459.v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

From CGRP to PACAP: Unraveling the Next Chapter in Migraine TreatmentDOI 10.20944/preprints202309.0459.v2Read

Migraine Treatment: Towards New Pharmacological TargetsSemantic proximity Read

Highly Sensitive Assays for detection of headache inducing neuropeptides, Pituitary adenylate cyclase-activating polypeptide (PACAP) and Calcitonin gene-related peptide (CGRP)Semantic proximity Read

Atogepant: Mechanism of action, clinical and translational scienceSemantic proximity Read

Cluster headache: new targets and options for treatmentSemantic proximity Read

Treating episodic migraine with precision: the evolving landscape of targeted therapies driven by insights in disease biologySemantic proximity Read

Recent advances in the management of migraineSemantic proximity Read

Novel Calcitonin Gene-Related Peptide (CGRP) Interfering Migraine Therapies and Stroke – A ReviewSemantic proximity Read

Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity Read

Serum CGRP, VIP, and PACAP Usefulness in Migraine: A Case-Control Study in Chronic Migraine Patients in Real Clinical Practice.Semantic proximity Read

Safety efficacy and tolerability of the calcitonin gene-related peptide monoclonal antibodies for migraine prevention in a real world settingSemantic proximity Read

Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-AnalysisSemantic proximity Read

Effectiveness and Tolerability of Anti-Calcitonin Gene-related Peptide Therapy for Migraines and Other Chronic Headaches in Adolescents and Young Adults: A Retrospective Study in the USASemantic proximity Read